Avanir appoints Zalicus president to board
This article was originally published in Scrip
Executive Summary
California-based biopharmaceutical company Avanir Pharmaceuticals has appointed Dr Mark Corrigan to its board of directors. Dr Corrigan currently serves as president and CEO of Zalicus, a position he has held since 2010.